Julia Tanndal is an associate at Cornerstone Research based in the firm’s London office. She provides economic analysis and litigation expert support in the UK, United States, and Europe. She has worked on cases related to pharmaceutical antitrust litigation, vertical and horizontal mergers, and regulatory enforcement of competition policy and data privacy.
1130
One goal of the European Commission’s proposed reform to existing regulations is to increase patient access to innovative medicines across the European Union. We describe the economic impact of this policy change. Because of the incentives created by other policies, particularly external (...)
